University Hospital of Alexandroupolis
Alexandroupoli, Evros, 68100, Greece
Location status: Recruiting
NCT Number: NCT07077967
Primary objective of this study is to introduce a modified luminous efficiency function that addresses the distinct total eye light transmittance of patients who underwent pseudophakic presbyopic correction with extended-depth of focus (EDOF) intraocular lenses (IOLs) implantations.
Interested in participating?
Request Info45 year–75 year
All sexes
Observational
Alexandroupoli, Evros, 68100, Greece
Location status: Recruiting
Present study aims to identify in which degree EDOF IOLs modify eye light transmission and estimate the necessary task and environmental lighting adjustment in order to address lighting needs of patients following pseudophakic presbyopic corrections implanted with EDOF IOLs. Specifically, the aim of this study is to identify the minimum light intensity at which patients who underwent pseudophakic presbyopic correction with EDOF IOLs can reach their maximum visual acuity (measured when lights are at the 100% lighting level)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Uneventful pseudophakic presbyopic correction with EDOF IOLs
Time frame: 6 months postoperatively
Minimum Required Illuminance Level (MRIL) (in lx) at which participants reach their optimal Uncorrected Distance Visual Acuity.
Interested in participating?
Request InfoDemocritus University of Thrace
Other
Impact of Artificial Lighting on Visual Acuity After Presbyopia Correction With an Extended Depth of Focus Intraocular Lens: Introduction of a Modified Luminous Efficiency Function V(λ)'
Acronym: V(λ)'_EDOF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05955846
Cataract, Eye Diseases
Coimbra, Portugal
View Trial DetailsNCT03135327
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Miami, Florida, United States
View Trial DetailsNCT07637500
Eye Diseases, Presbyopia
Heidelberg, Germany
View Trial DetailsNCT07512089
Eye Diseases, Presbyopia
Guangzhou, Guangdong, China
View Trial Details